Clinical Trial Update: Treatment of Acute Ischemic Stroke With Edaravone Dexborneol Sublingual Tablets in Small Vessel Disease [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating edaravone dexborneol sublingual tablets for acute ischemic stroke in cerebral small-vessel disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Small Vessel Disease
• Stroke

Drugs mentioned

• Edaravone dexborneol sublingual tablets (edaravone-dexborneol)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Cerebral Small Vessel Disease, Ischemic Stroke | Phase 3 | Status: RECRUITING